Literature DB >> 20638372

Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system.

Julián Esteve-Rudd1, Laura Campello, María-Trinidad Herrero, Nicolás Cuenca, José Martín-Nieto.   

Abstract

The ubiquitin-proteasome system (UPS) functions as a major degradation pathway for misfolded and damaged proteins with an important neuroprotective role in the CNS against a variety of cellular stresses. Parkin and ubiquitin C-terminal hydrolase L1 (UCH-L1) are two relevant components of the UPS associated with a number of neurodegenerative disorders. We here address the expression profile of parkin and UCH-L1 in the mammalian retina, with special emphasis on primates. We describe for the first time the presence of parkin in the retina of mammals, including humans. Parkin and UCH-L1 genes were expressed at the mRNA and protein levels in the retina of all species examined. The immunolocalization pattern of parkin was quite widespread, being expressed by most retinal neuronal types, including photoreceptors. UCH-L1 was localized to horizontal cells and specific subtypes of bipolar and amacrine cells, as well as to ganglion cells and their axons forming the nerve fiber layer. In rodents no UCH-L1 immunoreactivity was found in cone or rod photoreceptors, whereas this protein was present along the whole length of cones in all other mammals. Remarkably, UCH-L1 was expressed by dopaminergic amacrine cells of primates. The ample distribution of parkin and UCH-L1 in the mammalian retina, together with the crucial role played by the UPS in normal neuronal physiology in the brain, points to a participation of these two proteins in the ubiquitin-proteasomal pathway of protein degradation in most retinal cell types, where they could exert a protective function against neuronal stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638372     DOI: 10.1016/j.brainres.2010.07.019

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

Review 1.  Mechanisms for countering oxidative stress and damage in retinal pigment epithelium.

Authors:  Scott M Plafker; Gary B O'Mealey; Luke I Szweda
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Translational profiling of retinal ganglion cell optic nerve regeneration in Xenopus laevis.

Authors:  G B Whitworth; B C Misaghi; D M Rosenthal; E A Mills; D J Heinen; A H Watson; C W Ives; S H Ali; K Bezold; N Marsh-Armstrong; F L Watson
Journal:  Dev Biol       Date:  2016-07-26       Impact factor: 3.582

Review 3.  Autophagy in light-induced retinal damage.

Authors:  Yu Chen; Lindsay Perusek; Akiko Maeda
Journal:  Exp Eye Res       Date:  2015-09-07       Impact factor: 3.467

Review 4.  The ubiquitin-proteasome system in retinal health and disease.

Authors:  Laura Campello; Julián Esteve-Rudd; Nicolás Cuenca; José Martín-Nieto
Journal:  Mol Neurobiol       Date:  2013-01-22       Impact factor: 5.590

5.  Autophagy protects the retina from light-induced degeneration.

Authors:  Yu Chen; Osamu Sawada; Hideo Kohno; Yun-Zheng Le; Carlos Subauste; Tadao Maeda; Akiko Maeda
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

Review 6.  Working your SOCS off: The role of ASB10 and protein degradation pathways in glaucoma.

Authors:  Kate E Keller; Mary K Wirtz
Journal:  Exp Eye Res       Date:  2016-06-11       Impact factor: 3.467

7.  Remodeling of the fovea in Parkinson disease.

Authors:  B Spund; Y Ding; T Liu; I Selesnick; S Glazman; E M Shrier; I Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  2012-12-23       Impact factor: 3.575

8.  Enhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus.

Authors:  Hongtao Liu; Shujie Yu; Wenjia Xu; Jian Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-05       Impact factor: 8.311

9.  Proteomic profiling of human retinal pigment epithelium exposed to an advanced glycation-modified substrate.

Authors:  J V Glenn; H Mahaffy; S Dasari; M Oliver; M Chen; M E Boulton; H Xu; W J Curry; Alan W Stitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-13       Impact factor: 3.117

10.  Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats.

Authors:  Shasha Liu; Chengfang Wang; Jianmin Lu; Guangzheng Dai; Huixin Che; Wei He
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.